West China Hospital: Breast Neoplasms trials

The registry lists 10 Breast Neoplasms studies with West China Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 4Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone MetastasesNot yet recruitingNCT07687225Not applicable
• Akkermansia Muciniphila (AKK) for Radiation-Induced Skin InjuryRecruitingNCT07635277Phase 1
• The Comparison Between DEDTI BR and T/E BRNot yet recruitingNCT07593846Phase 3
• Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast CancerNot yet recruitingNCT07311317
• Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)RecruitingNCT05447702Phase 2
• Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort StudyCompletedNCT06603805
• Disitamab Vedotin(RC48) Combined With Penpulimab(AK105) for Neoadjuvant Treatment of HER2-low Breast CancerStatus unknownNCT05726175Phase 2
• A Study on the Effectiveness of WeChat-based Online Education to Reduce Perioperative Anxiety in Breast Cancer PatientsCompletedNCT05291494Not applicable
• Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast CancerStatus unknownNCT04917900Phase 2
• Pyrotinib Maleate Tablets Combined With Albumin Paclitaxel and Trastuzumab for Her2-positive Breast CancerStatus unknownNCT04152057Phase 1/2